Yunhua Zhang

Yunhua Zhang

Auto-generated profile, based on publicly available information

Yunhua Zhang

Department of General Surgery, Jincheng People’s Hospital, Jincheng 048026, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2021 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
FZFeng Zhu
Feng Zhu
JMJing Ma
Jing Ma
DRDongdong Ru
Dongdong Ru
NWNingning Wu
Ningning Wu
YZYunhua Zhang
Yunhua Zhang
WFWeihua Fu
Weihua Fu
Objectives. To verify whether the concentrations and integrity index of circulating cell-free DNA (cfDNA) in serum may be clinically useful for the progression monitoring of colorectal cancer (CRC) patients. Methods. Serum samples were collected from 76 primary CRC patients who underwent surgery, including 60 with chemotherapy and 43 with follow-up. Long (247bp) and short (115bp) DNA fragments in serum were detected by real-time quantitative PCR by amplifying the ALU repeats. Ten serum traditional biomarkers levels were detected by chemiluminescence immunoassay assay. Results. The median DNA integrity index (ALU247/ALU115) of serum DNA in the preoperative group was significantly higher than those in the postchemotherapy and the follow-up groups, while cfDNA concentration (ALU115) was significantly lower in the preoperative group compared with the postchemotherapy and the follow-up groups. CEA and CA242 were significantly lower in the postoperative group than in the preoperative group. Conclusions. Serum DNA integrity index (ALU247/115) may prove to be a promising candidate biomarker for prognostic prediction of CRC who underwent chemotherapy and during short-term follow-up.